Auf dieser Seite
01COO Preis
02Momentaufnahme
03Chart
04Aktiensplits
05Über uns
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
25Handelssignale
26Meine Kennzahlen
COO The Cooper Companies, Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Sep 9, 2026
$56,91
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$51,0152-Wochen-Tief
$89,8352-Wochen-Hoch
Marktkapitalisierung (MRQ)
$10.82B
P/E (TTM)
19.5
EPS (TTM)
$2.92
Umsatz (TTM)
$4.24B
Ihre Abzeichen
52W-Spanne
$51–$90
Analystenbewertung
HOLD
Kursziel
$66
P/E
19.5
ROE
6.8%
Nettogewinnmarge
13.5%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
COO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$56.91
Marktkapitalisierung (MRQ)
$10.82B
P/E (TTM)
19.5
EPS (TTM)
$2.92
Umsatz (TTM)
$4.24B
Dividendenrendite
0.00%
ROE (TTM)
6.8%
Verschuldungsgrad (MRQ)
0.3
52W-Spanne
$51–$90
COO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 20. Februar 2024 | 4-for-1 | Vorwärts |
| 25. November 2002 | 2-for-1 | Vorwärts |
| 22. September 1995 | 1-for-3 | Umgekehrt |
Über The Cooper Companies, Inc. - Common Stock Unternehmensübersicht von Wikipedia
Die The Cooper Companies Inc. mit Hauptsitz in Pleasanton, Kalifornien ist ein US-amerikanisches Unternehmen in der Gesundheitsbranche.
The Cooper Companies ist weltweit einer der größten Hersteller von Kontaktlinsen, insbesondere im Segment der torischen Speziallinsen. Die Kontaktlinsen von Cooper Companies werden in sieben unternehmenseigenen Produktionsstätten gefertigt, u. a. in Rochester, Adelaide und Madrid.
Größere Vertriebszentralen des Unternehmens befinden sich im Vereinigten Königreich und in den USA.
Struktur
CooperVision
CooperVision ist eine Gesellschaft der Cooper Companies. Die Hälfte seiner 20 Niederlassungen ist in Europa ansässig. CooperVision beschäftigt weltweit ca. 8.600 Mitarbeiter, davon allein 2.500 in den europäischen Ländern, und unterhält sieben unternehmenseigene Produktionsstätten an internationalen Standorten. Geschäftszweck von CooperVision ist vor allem die Produktion von Kontaktlinsen.
2011 kündigte CooperVision eine neue Markenpositionierung und visuelle Erscheinung an, welche von Siegel+Gale, einer weltweit tätigen Branding-Firma, entwickelt wurde. Dieses Rebranding gewann 2012 als eine von fünf Unternehmen den „Best of Awards“ von REBRAND. Im Jahr 2013 arbeiteten Forscher von CooperVision in Zusammenarbeit mit Linköpings Universität (Schweden), der Universität von Ottawa (Kanada), FibroGen Inc (USA) und Synsam Opticians (Schweden) an einer Studie zu künstlichen Hornhäuten. Diese Studie wurde in der Zeitschrift Science Translational Medicine veröffentlicht, außerdem hat die BBC (British Broadcasting Corporation) in einem Beitrag darüber berichtet.
CooperSurgical
Cooper Surgical stellt verschiedene Medizinprodukte mit Schwerpunkt auf medizinische Produkte für Frauen.
Unternehmensgeschichte
Cooper Companies Inc. wurde 1958 ursprünglich als Martin H. Smith Co. gegründet, 1967 wurde der Firmenname zu Cooper Laboratories Inc. geändert. Im Jahre 1978 kam es zu einer Reorganisierung in Cooper Laboratories, Cooper Medical Devices, Cooper Dental, Cooper International und CooperVision. CooperVision wurde 1980 als Aktiengesellschaft (Inc) eingetragen und der Börsengang erfolgte 1983. CooperVision Inc. veränderte 1987 erneut den Namen zu The Cooper Companies Inc. und untergliederte sich in 3 Geschäftsbereiche: Cooper Technicon, CooperSurgical und CooperVision.
Die Aktionäre der beiden Unternehmen The Cooper Companies und Ocular Sciences (OSI) haben am 16. November 2004 der Übernahme von OSI zugestimmt. Die Aufsichtsbehörden hatten die Zustimmung erteilt und das Abschlussdatum damit festgesetzt. Mit diesem Datum ging das Eigentum von Ocular Sciences auf den Geschäftsbereich CooperVision über. Mit der Übernahme von Ocular Sciences ist der amerikanische Kontaktlinsenhersteller CooperVision seit Beginn des Jahres 2005 auch auf dem deutschen Markt vertreten.
Wichtige Produkte
CooperVision entwickelt, erzeugt und vermarktet weltweit eine breite Palette von Kontaktlinsen, darunter auch eine biokompatible Kontaktlinsenfamilie. Das hierfür verwendete Kontaktlinsenmaterial Omafilcon A enthält als Polymerbestandteil eine synthetische Kopie des Stoffes Phosphorylcholin, kurz PC genannt. Phosphorylcholin kommt als Molekülbestandteil in allen menschlichen, tierischen und pflanzlichen Zellen vor und findet in der Biomedizin, so z. B. in Bypässen, bereits seit geraumer Zeit Anwendung, da es als körpereigener Stoff erkannt wird.
Soziales Engagement
CooperVision ist an verschiedenen Projekten und Stipendienprogrammen beteiligt.
Das Unternehmen vergibt ein Studien-Forschungsstipendium, welches Optometrie-Studenten ermutigen soll, sich an Kontaktlinsen-basierten Forschungsprojekten zu beteiligen.
Im Jahr 2012 spendeten The Cooper Companies, Inc. und CooperVision 100.000 US-Dollar an die Optometry Giving Sight World Sight Day Challenge.
CooperVision ist ein Gründungsschirmherr und Sponsor des Optometry Giving Sight, einem globalen Spenden-Programm, welches zum Ziel hat, weltweit den Zugang zu Augenuntersuchungen und Brillen zu erleichtern.
Das Unternehmen initiierte auch die One Bright Vision-Kampagne in Partnerschaft mit Optometry Giving Sight.
Auszeichnungen
CooperVision erhielt im Jahr 2013 für die Kontaktlinsen MyDay den Preis SILMO d’Or.
Niederlassungen in Europa
Frankreich Frankreich: Sophia Antipolis
Deutschland Deutschland: Darmstadt
Italien Italien: Lainate
Niederlande Niederlande: Gorinchem
Schweden Schweden: Stockholm
Schweden Schweden: Mölndal
Vereinigtes Konigreich Vereinigtes Königreich: Hamble-le-Rice, Borough of Eastleigh
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealth Care
BrancheHealth Care
Mitarbeiter15.000
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$4.09B2016-10-31 → 2025-10-31
EPS$1.872016-10-31 → 2025-10-31
Freier Cashflow$434M2016-10-31 → 2025-10-31
Nettogewinnmarge13.5%2016-10-31 → 2025-10-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | COO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 19.55-Jahres-Durchschnitt ≈36.1 | ≈36.1 | 28.5 | Unterbewertet | |
| P/S (TTM) | 2.65-Jahres-Durchschnitt ≈2.5 | ≈2.5 | 2.1 | Überbewertet | |
| K/B (MRQ) | 1.35-Jahres-Durchschnitt ≈1.2 | ≈1.2 | 2.1 | Unterbewertet | |
| EV / EBITDA | 12.85-Jahres-Durchschnitt ≈13.5 | ≈13.5 | 16.6 | Fairer Wert | |
| Kurs / FCF (TTM) | 16.05-Jahres-Durchschnitt ≈27.9 | ≈27.9 | · | · | |
| Kurs / Cashflow (TTM) | 10.55-Jahres-Durchschnitt ≈13.0 | ≈13.0 | 17.6 | Fairer Wert | |
| EV / Revenue (EV / Umsatz) | 3.35-Jahres-Durchschnitt ≈3.1 | ≈3.1 | · | · | |
| EV / FCF | 31.25-Jahres-Durchschnitt ≈34.4 | ≈34.4 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 1.65-Jahres-Durchschnitt ≈3.8 | ≈3.8 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | COO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 65.9%5-Jahres-Durchschnitt ≈65.9% | ≈65.9% | 58.2% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | 12.8%5-Jahres-Durchschnitt ≈16.5% | ≈16.5% | 11.8% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 21.9%5-Jahres-Durchschnitt ≈22.3% | ≈22.3% | 17.6% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 10.9%5-Jahres-Durchschnitt ≈14.3% | ≈14.3% | 10.1% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 13.5%5-Jahres-Durchschnitt ≈28.0% | ≈28.0% | 6.7% | Spitzenklasse | |
| ROA (TTM) | 4.6%5-Jahres-Durchschnitt ≈9.7% | ≈9.7% | 3.5% | Im Einklang | |
| ROE (TTM) | 6.8%5-Jahres-Durchschnitt ≈14.8% | ≈14.8% | 6.5% | Unterdurchschnittlich | |
| ROIC | 4.2%5-Jahres-Durchschnitt ≈10.6% | ≈10.6% | 5.1% | Unterdurchschnittlich |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | COO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.35-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.5 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 1.25-Jahres-Durchschnitt ≈1.8 | ≈1.8 | 1.7 | Geringe Liquidität | |
| Quick Ratio | 0.85-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 0.5 | Im Einklang | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.25-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.8 | Geringe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | COO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 5.1%5-Jahres-Durchschnitt ≈11.1% | ≈11.1% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 7.3%5-Jahres-Durchschnitt ≈10.4% | ≈10.4% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 11.0% | · | · | · | |
| EPS YoY (EPS VjV) | -4.6%5-Jahres-Durchschnitt ≈207.5% | ≈207.5% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -4.4%5-Jahres-Durchschnitt ≈210.7% | ≈210.7% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -1.2%5-Jahres-Durchschnitt ≈-33.9% | ≈-33.9% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -17.2% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -0.95%5-Jahres-Durchschnitt ≈-14.2% | ≈-14.2% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 9.5% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | COO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.35-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.6 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 1.75-Jahres-Durchschnitt ≈1.8 | ≈1.8 | 2.7 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 5.35-Jahres-Durchschnitt ≈5.9 | ≈5.9 | 7.7 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$272.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite0.00%
Ausschüttungsquote0.00%
Annualisierte Auszahlung≈$0.01
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Jul 26, 2023 | $0,01 | USD | ≈0.02% |
| Jan 20, 2023 | $0,01 | USD | ≈0.02% |
| Jul 26, 2022 | $0,01 | USD | ≈0.02% |
| Jan 20, 2022 | $0,01 | USD | ≈0.02% |
| Jul 26, 2021 | $0,01 | USD | ≈0.01% |
| Jan 21, 2021 | $0,01 | USD | ≈0.02% |
| Jul 22, 2020 | $0,01 | USD | ≈0.02% |
| Jan 22, 2020 | $0,01 | USD | ≈0.02% |
| Jul 22, 2019 | $0,01 | USD | ≈0.02% |
| Jan 18, 2019 | $0,01 | USD | ≈0.02% |
| Jul 20, 2018 | $0,01 | USD | ≈0.02% |
| Jan 22, 2018 | $0,01 | USD | ≈0.02% |
| Jul 19, 2017 | $0,01 | USD | ≈0.02% |
| Jan 19, 2017 | $0,01 | USD | ≈0.03% |
| Jul 20, 2016 | $0,01 | USD | ≈0.03% |
| Jan 20, 2016 | $0,01 | USD | ≈0.05% |
| Jul 22, 2015 | $0,01 | USD | ≈0.03% |
| Jan 21, 2015 | $0,01 | USD | ≈0.04% |
| Jul 22, 2014 | $0,01 | USD | ≈0.04% |
| Jan 22, 2014 | $0,01 | USD | ≈0.05% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
3.9%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. September 2026 | Sep 9, 2026 | $1.15 | $1.13 | 1.8% |
| 30. Juni 2026 | Jun 4, 2026 | $1.21 | $1.11 | 9.3% |
| 31. März 2026 | $1.10 | $1.04 | 5.7% | |
| 31. Dezember 2025 | $1.15 | $1.12 | 2.3% | |
| 30. September 2025 | $1.10 | $1.08 | 1.9% | |
| 30. Juni 2025 | $0.96 | $0.94 | 2.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B | $2.14B | $1.97B | $1.80B | $1.72B | |
| Cost of Revenue | $1.41B | $1.30B | $1.24B | $1.17B | $967M | $896M | $897M | $900M | $773M | $794M | $727M | $626M | |
| Gross Profit | $2.68B | $2.60B | $2.36B | $2.14B | $1.96B | $1.53B | $1.76B | $1.63B | $1.37B | $1.17B | $1.07B | $1.09B | |
| R&D Expense | $172M | $155M | $137M | $110M | $93M | $93M | $87M | $85M | $69M | $65M | $70M | $66M | |
| SG&A Expense | $1.63B | $1.53B | $1.50B | $1.34B | $1.21B | $992M | $996M | $973M | $799M | $723M | $712M | $683M | |
| Operating Income | $683M | $706M | $533M | $508M | $506M | $312M | $547M | $403M | $429M | $324M | $237M | $306M | |
| Interest Expense | · | · | $105M | $57M | $23M | $37M | $68M | $83M | $33M | $26M | $18M | $8M | |
| Other Non-op | $-16M | $-9M | $-15M | $25M | $9M | $-8M | $-1M | $12M | $-2M | $-2M | $-3M | $-2M | |
| Pretax Income | $566M | $582M | $413M | $475M | $492M | $266M | $477M | $332M | $394M | $296M | $216M | $296M | |
| Income Tax | $192M | $190M | $119M | $90M | $-2.45B | $28M | $11M | $192M | $21M | $21M | $10M | $25M | |
| Net Income | $375M | $392M | $294M | $386M | $2.94B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | |
| EPS (Basic) | $1.88 | $1.97 | $1.49 | $1.95 | $59.80 | $4.85 | $9.44 | $2.85 | $7.63 | $5.65 | $4.20 | $5.61 | |
| EPS (Diluted) | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 | $4.81 | $9.33 | $2.81 | $7.52 | $5.59 | $4.14 | $5.51 | |
| Shares (Basic) | 199,100,000 | 198,900,000 | 197,900,000 | 197,400,000 | 49,200,000 | 49,100,000 | 49,400,000 | 49,100,000 | 48,900,000 | 48,500,000 | 48,500,000 | 48,061,000 | |
| Shares (Diluted) | 200,000,000 | 200,400,000 | 199,300,000 | 198,800,000 | 49,800,000 | 49,600,000 | 50,000,000 | 49,700,000 | 49,600,000 | 49,000,000 | 49,200,000 | 49,000,000 | |
| EBITDA | $1.06B | $1.08B | $901M | $508M | $506M | $312M | $828M | $678M | $618M | $522M | $428M | $445M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $108M | $121M | $138M | $96M | $116M | $89M | $78M | $89M | $101M | $16M | $25M | |
| Receivables | $829M | $717M | $610M | $558M | $515M | $435M | $435M | $375M | $317M | $291M | $283M | $276M | |
| Inventory | $846M | $803M | $736M | $629M | $586M | $570M | $507M | $469M | $454M | $418M | $420M | $382M | |
| Prepaid Expense | $321M | $324M | $239M | $209M | $179M | $152M | $132M | $170M | $94M | $78M | $81M | $68M | |
| Current Assets | $2.11B | $1.95B | $1.70B | $1.53B | $1.47B | $1.27B | $1.16B | $1.09B | $953M | $937M | $841M | $792M | |
| PP&E (Net) | $2.08B | $1.86B | $1.63B | $1.41B | $1.35B | $1.28B | $1.13B | $976M | $910M | $878M | $967M | $937M | |
| PP&E (Gross) | $3.91B | $3.56B | $3.18B | $2.80B | $2.66B | $2.47B | $2.19B | $1.93B | $1.76B | $1.60B | $1.65B | $1.53B | |
| Accum. Depreciation | $1.83B | $1.70B | $1.55B | $1.39B | $1.31B | $1.19B | $1.06B | $954M | $847M | $726M | $684M | $589M | |
| Goodwill | $3.85B | $3.84B | $3.62B | $3.61B | $2.57B | $2.45B | $2.43B | $2.39B | $2.35B | $2.16B | $2.20B | $2.22B | |
| Intangibles | $1.59B | $1.79B | $1.71B | $1.89B | $1.27B | $1.29B | $1.41B | $1.52B | $505M | $441M | $411M | $454M | |
| Other Non-current Assets | $689M | $661M | $637M | $588M | $401M | $105M | $67M | $74M | $76M | $52M | $39M | $39M | |
| Total Assets | $12.39B | $12.32B | $11.66B | $11.49B | $9.61B | $6.74B | $6.27B | $6.11B | $4.86B | $4.48B | $4.46B | $4.46B | |
| Accounts Payable | $300M | $260M | $262M | $249M | $161M | $176M | $150M | $146M | $142M | $107M | $117M | $116M | |
| Short-term Debt | $47M | $32M | $44M | $396M | $83M | $409M | $564M | $37M | $23M | $226M | $244M | $102M | |
| Current Liabilities | $1.11B | $1.02B | $969M | $1.28B | $732M | $1.00B | $1.11B | $536M | $396M | $543M | $569M | $442M | |
| Capital Leases | $240M | $231M | $216M | $206M | $232M | $237M | · | · | · | · | · | · | |
| Deferred Tax | $93M | $96M | $102M | $150M | $24M | $26M | $28M | $31M | $39M | $38M | $31M | $70M | |
| Other Non-current Liabilities | $283M | $312M | $239M | $225M | · | · | · | · | · | · | · | · | |
| Total Liabilities | $4.16B | $4.23B | $4.11B | $4.32B | $2.66B | $2.91B | $2.65B | $2.81B | $1.68B | $1.78B | $1.79B | $1.87B | |
| Long-term Debt | · | · | · | · | · | · | · | $1.99B | $1.15B | $1.32B | $1.11B | $1.28B | |
| Total Debt | $2.50B | $2.58B | $2.56B | $2.35B | $1.40B | $1.38B | $1.26B | $2.02B | $1.17B | $1.54B | $1.35B | $1.38B | |
| Common Stock | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Paid-in Capital | $1.98B | $1.92B | $1.82B | $1.77B | $1.72B | $1.65B | $1.61B | $1.57B | $1.53B | $1.49B | $1.43B | $1.39B | |
| Retained Earnings | $7.64B | $7.27B | $6.88B | $6.58B | $6.20B | $3.26B | $3.03B | $2.58B | $2.43B | $2.05B | $1.78B | $1.58B | |
| Treasury Stock | $995M | $706M | $710M | $714M | $640M | $617M | $571M | $415M | $415M | $360M | $360M | $295M | |
| AOCI | $-406M | $-422M | $-454M | $-467M | $-341M | $-472M | $-447M | $-431M | $-375M | $-490M | $-192M | $-106M | |
| Stockholders' Equity | $8.24B | $8.08B | $7.55B | $7.17B | $6.94B | $3.82B | $3.63B | $3.31B | $3.18B | $2.70B | $2.67B | $2.57B | |
| Liabilities + Equity | $12.39B | $12.32B | $11.66B | $11.49B | $9.61B | $6.74B | $6.27B | $6.11B | $4.86B | $4.48B | $4.46B | $4.46B | |
| Shares Outstanding | 195,900,000 | 199,600,000 | 198,100,000 | 49,300,000 | 49,300,000 | 49,100,000 | · | · | 48,800,000 | 48,800,000 | 48,300,000 | 48,100,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $377M | $375M | $368M | $346M | $309M | · | $281M | $275M | $188M | $198M | $191M | $138M | |
| Stock-based Comp | $70M | $75M | $62M | $54M | $44M | $38M | $35M | $43M | $37M | $30M | $33M | $37M | |
| Deferred Tax | $135M | $119M | $45M | $54M | $-2.50B | $-900.0K | $-16M | $3M | $-7M | $-11M | $6M | $-16M | |
| Amort. of Intangibles | $199M | $201M | $186M | $180M | $146M | $137M | $146M | $147M | $68M | $61M | $52M | $36M | |
| Other Non-cash | $-162M | $-252M | $-161M | · | · | · | $-54M | $208M | $2M | $18M | $-42M | $26M | |
| Operating Cash Flow | $796M | $709M | $608M | $692M | $739M | $487M | $713M | $669M | $594M | $510M | $391M | $455M | |
| CapEx | $362M | $421M | $392M | $242M | $214M | $310M | $292M | $194M | $127M | $153M | $243M | $238M | |
| Investing Cash Flow | $-373M | $-765M | $-449M | $-1.83B | $-450M | $-364M | $-351M | $-1.52B | $-381M | $-419M | $-288M | $-1.35B | |
| Debt Issued | $3.11B | $3.52B | $2.12B | $1.51B | $1.43B | $3.20B | $1.14B | $2.75B | $1.41B | $1.58B | $1.20B | $2.56B | |
| Net Debt Issued | $-94M | $17M | $170M | $950M | $12M | $-30M | $-725M | $836M | $49M | $117M | $-171M | $895M | |
| Stock Repurchased | $290M | $0 | $0 | $78M | $25M | $48M | $156M | $0 | $55M | $0 | $67M | $76M | |
| Net Stock Activity | $-290M | $0 | $0 | $-78M | $-25M | $-48M | $-156M | $0 | $-55M | $0 | $-67M | $-76M | |
| Dividends Paid | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Financing Cash Flow | $-426M | $39M | $-174M | $1.19B | $-311M | $-96M | $-351M | $844M | $-228M | $-1M | $-107M | $842M | |
| Net Change in Cash | $3M | $-13M | $-18M | $42M | $-20M | $27M | $9M | $-9M | $-12M | $84M | $-9M | $-52M | |
| Taxes Paid | · | · | · | · | · | · | · | $19M | $16M | $29M | $12M | $16M | |
| Free Cash Flow | $434M | $288M | $215M | $450M | $524M | $176M | $421M | $475M | $466M | $357M | $148M | $217M | |
| Levered FCF | · | · | $140M | $404M | $386M | · | · | $440M | $435M | $333M | $131M | $209M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% | 63.1% | 66.2% | 64.5% | 63.8% | 59.6% | 59.6% | 63.5% | |
| Operating Margin | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% | 12.8% | 20.6% | 15.9% | 20.1% | 16.5% | 13.2% | 17.8% | |
| Net Margin | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% | 17.4% | 13.9% | 11.3% | 15.7% | |
| Pretax Margin | 13.8% | 14.9% | 11.5% | 14.4% | 16.8% | · | · | 13.1% | 18.4% | 15.0% | 12.0% | 17.3% | |
| EBITDA Margin | 25.9% | 27.8% | 25.1% | 15.3% | 17.3% | 12.8% | 31.2% | 26.8% | 28.9% | 26.6% | 23.8% | 25.9% | |
| ROA | 3.0% | 3.3% | 2.5% | 3.7% | 36.0% | 3.7% | 7.5% | 2.5% | 8.0% | 6.1% | 4.6% | 7.1% | |
| ROE | 4.6% | 5.0% | 4.0% | 5.5% | 54.7% | 6.4% | 13.0% | 4.3% | 12.7% | 10.2% | 7.8% | 10.8% | |
| ROIC | 4.2% | 4.5% | 3.8% | 4.3% | 36.3% | · | · | 3.2% | 9.3% | 7.1% | 5.6% | 7.1% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.9 | 1.8 | 1.2 | 2.0 | 1.3 | 1.0 | 2.0 | 2.4 | 1.7 | 1.5 | 1.8 | |
| Quick Ratio | 0.8 | 0.8 | 0.8 | 0.5 | 0.8 | 0.5 | 0.5 | 0.8 | 1.0 | 0.7 | 0.5 | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.6 | 0.4 | 0.6 | 0.5 | 0.5 | |
| LT Debt / Equity | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.6 | 0.4 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | 5.1 | 8.9 | 21.9 | 8.5 | 8.0 | 4.9 | 12.8 | 12.4 | 13.1 | 38.5 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | 0.5 | |
| Inventory Turnover | 1.7 | 1.7 | 1.8 | 1.9 | 1.7 | 1.7 | 1.8 | 2.0 | 1.8 | 1.9 | 1.8 | 1.7 | |
| Receivables Turnover | 5.3 | 5.9 | 6.2 | 6.2 | 6.1 | 5.6 | 6.6 | 7.3 | 7.0 | 6.8 | 6.4 | 6.8 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $42.06 | $40.50 | $152.54 | $145.53 | $140.81 | · | · | · | $65.08 | $55.34 | $55.26 | $53.38 | |
| Revenue / Share | $20.46 | $19.44 | $72.15 | $66.57 | $58.68 | $49.01 | $53.07 | $50.96 | $43.12 | $40.14 | $36.54 | $35.09 | |
| Cash Flow / Share | $3.98 | $3.54 | $12.20 | $13.93 | $14.83 | $9.81 | $14.26 | $13.46 | $11.97 | $10.40 | $7.95 | $9.29 | |
| Cash / Share | $0.56 | $0.54 | $2.44 | $2.80 | $1.95 | · | · | · | $1.82 | $2.07 | $0.34 | $0.52 | |
| Dividend / Share | · | · | $0.01 | $0.01 | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | · | · | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | |
| EPS (TTM) | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 | $4.81 | $9.33 | $2.81 | $7.52 | $5.59 | $4.14 | $5.51 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.1% | 8.4% | 8.6% | 13.2% | 20.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.3% | 10.1% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.6% | 32.4% | -23.7% | -96.7% | 1129.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -1.2% | -67.9% | -32.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -4.4% | 33.3% | -23.7% | -86.9% | 1135.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -0.95% | -48.9% | 7.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B | $2.14B | $1.97B | $1.80B | $1.72B | |
| Net Income TTM | $375M | $392M | $294M | $386M | $2.94B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | |
| Market Cap | $13.70B | $20.89B | $3.86B | $3.37B | $5.14B | · | · | · | $2.93B | $2.15B | $1.84B | $1.97B | |
| Enterprise Value | $16.09B | $23.37B | $6.30B | $5.58B | $6.44B | · | · | · | $4.02B | $3.59B | $3.18B | $3.33B | |
| P/E | 37.4 | 53.4 | 52.7 | 35.2 | 1.8 | 16.6 | 7.8 | 23.0 | 8.0 | 7.9 | 9.2 | 7.4 | |
| P/S | 3.3 | 5.4 | 1.1 | 1.0 | 1.8 | · | · | · | 1.4 | 1.1 | 1.0 | 1.1 | |
| P/B | 1.7 | 2.6 | 0.5 | 0.5 | 0.7 | · | · | · | 0.9 | 0.8 | 0.7 | 0.8 | |
| P / Tangible Book | 4.9 | 8.5 | 1.7 | 2.0 | 1.7 | · | · | · | · | · | · | · | |
| P / Cash Flow | 17.2 | 29.5 | 6.4 | 4.9 | 7.0 | · | · | · | 4.9 | 4.2 | 4.7 | 4.3 | |
| P / FCF | 31.6 | 72.5 | 17.9 | 7.5 | 9.8 | · | · | · | 6.3 | 6.0 | 12.4 | 9.1 | |
| EV / EBITDA | 15.2 | 21.6 | 7.0 | 11.0 | 12.7 | · | · | · | 6.5 | 6.9 | 7.4 | 7.5 | |
| EV / FCF | 37.1 | 81.1 | 29.3 | 12.4 | 12.3 | · | · | · | 8.6 | 10.1 | 21.5 | 15.4 | |
| EV / Revenue | 3.9 | 6.0 | 1.8 | 1.7 | 2.2 | · | · | · | 1.9 | 1.8 | 1.8 | 1.9 | |
| Dividend Yield | 0.00% | 0.00% | 0.08% | 0.09% | 0.06% | · | · | · | 0.10% | 0.14% | 0.16% | 0.15% | |
| Earnings Yield | 2.7% | 1.9% | 1.9% | 2.8% | 56.8% | 6.0% | 12.8% | 4.3% | 12.5% | 12.7% | 10.9% | 13.5% | |
| Payout Ratio | 0.00% | 0.00% | 1.0% | 0.78% | 0.10% | 1.3% | 0.64% | 2.1% | 0.78% | 1.1% | 1.4% | 1.1% | |
| Annual Payout | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $1.08B | $1.02B | $1.07B | $1.06B | $1.00B | $965M | $1.02B | $1.00B | $943M | $932M | $927M | $930M | $877M | $858M | $848M | |
| Cost of Revenue | $354M | $346M | $329M | $414M | $368M | $323M | $304M | $341M | $340M | $311M | $308M | $321M | $320M | $294M | $300M | $311M | |
| Gross Profit | $712M | $735M | $695M | $651M | $692M | $679M | $660M | $678M | $663M | $631M | $624M | $606M | $610M | $583M | $558M | $537M | |
| R&D Expense | $42M | $42M | $44M | $41M | $45M | $46M | $41M | $38M | $39M | $39M | $40M | $37M | $36M | $33M | $32M | $29M | |
| SG&A Expense | $401M | $676M | $390M | $419M | $422M | $399M | $388M | $391M | $381M | $380M | $381M | $388M | $375M | $408M | $331M | $358M | |
| Operating Income | $222M | $-31M | $213M | $140M | $176M | $185M | $182M | $198M | $192M | $162M | $153M | $136M | $152M | $96M | $150M | $104M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $29M | $30M | · | $27M | $26M | $26M | · | |
| Other Non-op | $1M | $4M | $2M | $800.0K | $2M | $-16M | $-3M | $-3M | $-300.0K | $-3M | $-3M | $-3M | $-6M | $-5M | $-1M | $-8M | |
| Pretax Income | $202M | $-48M | $192M | $117M | $152M | $144M | $153M | $169M | $164M | $130M | $120M | $106M | $119M | $66M | $122M | $72M | |
| Income Tax | $-231M | $30M | $61M | $32M | $54M | $57M | $49M | $51M | $59M | $41M | $39M | $22M | $34M | $26M | $38M | $7M | |
| Net Income | $433M | $-78M | $131M | $85M | $98M | $88M | $104M | $118M | $105M | $89M | $81M | $84M | $85M | $40M | $85M | $66M | |
| EPS (Basic) | $2.24 | $-0.40 | $0.67 | $0.43 | $0.49 | $0.44 | $0.52 | $0.58 | $0.53 | $0.45 | $0.41 | $0.43 | $0.43 | $0.20 | $0.43 | $-4.54 | |
| EPS (Diluted) | $2.24 | $-0.40 | $0.66 | $0.42 | $0.49 | $0.44 | $0.52 | $0.59 | $0.52 | $0.44 | $0.41 | $0.42 | $0.43 | $0.20 | $0.43 | $-4.50 | |
| Shares (Basic) | 193,000,000 | 195,000,000 | 195,800,000 | · | 199,300,000 | 199,900,000 | 199,700,000 | · | 199,100,000 | 198,900,000 | 198,400,000 | · | 198,100,000 | 197,900,000 | 197,500,000 | · | |
| Shares (Diluted) | 193,400,000 | 195,000,000 | 196,700,000 | · | 200,000,000 | 200,700,000 | 201,200,000 | · | 200,600,000 | 200,500,000 | 199,900,000 | · | 199,600,000 | 199,200,000 | 198,700,000 | · | |
| EBITDA | $222M | $-31M | $308M | · | $176M | $185M | $273M | · | $192M | $162M | $250M | · | $152M | $96M | $239M | · |
Bilanz
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $155M | $139M | $125M | $111M | $125M | $116M | $101M | $108M | $110M | $112M | $135M | $121M | $117M | $112M | $118M | $138M | |
| Receivables | $789M | $809M | $807M | $829M | $792M | $781M | $716M | $717M | $739M | $689M | $651M | · | $630M | $565M | $582M | · | |
| Inventory | $912M | $896M | $876M | $846M | $881M | $880M | $843M | $803M | $779M | $775M | $748M | · | $724M | $699M | $659M | · | |
| Prepaid Expense | $426M | $455M | $325M | $321M | $340M | $348M | $327M | $324M | $299M | $282M | $260M | · | $240M | $224M | $218M | · | |
| Current Assets | $2.28B | $2.30B | $2.13B | $2.11B | $2.14B | $2.13B | $1.99B | $1.95B | $1.93B | $1.86B | $1.79B | · | $1.71B | $1.60B | $1.58B | · | |
| PP&E (Net) | · | · | · | $2.08B | · | · | · | $1.86B | $1.75B | $1.71B | $1.68B | · | $1.53B | $1.49B | $1.46B | · | |
| PP&E (Gross) | · | · | · | $3.91B | · | · | · | $3.56B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $1.83B | · | · | · | $1.70B | · | · | · | · | · | · | · | · | |
| Goodwill | $3.88B | $3.89B | $3.91B | $3.85B | $3.86B | $3.86B | $3.79B | $3.84B | $3.78B | $3.76B | $3.77B | · | $3.68B | $3.66B | $3.67B | · | |
| Intangibles | $1.45B | $1.49B | $1.54B | $1.59B | $1.64B | $1.69B | $1.74B | $1.79B | $1.79B | $1.80B | $1.85B | · | $1.77B | $1.81B | $1.86B | · | |
| Other Non-current Assets | $657M | $673M | $688M | $689M | $653M | $659M | $664M | $661M | $621M | $637M | $617M | · | $628M | $585M | $569M | · | |
| Total Assets | $12.67B | $12.48B | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | $11.66B | $11.70B | $11.54B | $11.56B | $11.49B | |
| Accounts Payable | $251M | $233M | $226M | $300M | $256M | $244M | $202M | $260M | $222M | $231M | $202M | · | $227M | $242M | $224M | · | |
| Short-term Debt | $628M | $598M | $620M | $47M | $46M | $59M | $48M | $32M | $40M | $41M | $45M | · | $63M | $58M | $52M | · | |
| Current Liabilities | $1.87B | $1.80B | $1.60B | $1.11B | $1.01B | $1.01B | $1000M | $1.02B | $970M | $952M | $965M | · | $994M | $949M | $916M | · | |
| Capital Leases | · | · | · | $240M | · | · | · | $231M | · | · | · | · | · | · | · | · | |
| Deferred Tax | $94M | $96M | $96M | $93M | $102M | $99M | $95M | $96M | $95M | $94M | $90M | · | $138M | $139M | $144M | · | |
| Other Non-current Liabilities | $257M | $266M | $277M | $283M | $263M | $274M | $261M | $312M | $277M | $278M | $281M | · | · | · | · | · | |
| Total Liabilities | $4.34B | $4.24B | $4.06B | $4.16B | $4.02B | $4.13B | $4.09B | $4.23B | $4.18B | $4.24B | $4.34B | · | $4.17B | $4.16B | $4.23B | · | |
| Total Debt | $2.54B | $2.46B | $2.50B | · | $2.48B | $2.58B | $2.54B | · | $2.63B | $2.71B | $2.77B | · | $2.57B | $2.62B | $2.68B | · | |
| Common Stock | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | · | $5M | $5M | $5M | · | |
| Paid-in Capital | $2.00B | $1.98B | $1.99B | $1.98B | $1.96B | $1.94B | $1.93B | $1.92B | $1.88B | $1.87B | $1.85B | · | $1.82B | $1.80B | $1.78B | · | |
| Retained Earnings | $8.13B | $7.70B | $7.77B | $7.64B | $7.56B | $7.46B | $7.37B | $7.27B | $7.15B | $7.05B | $6.96B | · | $6.79B | $6.71B | $6.67B | · | |
| Treasury Stock | $1.44B | $1.10B | $1.09B | $995M | $796M | $745M | $705M | $706M | $707M | $708M | $709M | · | $711M | $712M | $713M | · | |
| AOCI | $-383M | $-363M | $-334M | $-406M | $-392M | $-392M | $-490M | $-422M | $-425M | $-423M | $-422M | · | $-375M | $-424M | $-404M | · | |
| Stockholders' Equity | $8.33B | $8.24B | $8.36B | $8.24B | $8.35B | $8.29B | $8.13B | $8.08B | $7.92B | $7.80B | $7.70B | · | $7.53B | $7.38B | $7.34B | · | |
| Liabilities + Equity | $12.67B | $12.48B | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | · | $11.70B | $11.54B | $11.56B | · | |
| Shares Outstanding | 190,100,000 | 194,900,000 | 195,100,000 | 195,900,000 | 198,800,000 | 199,500,000 | 199,900,000 | 199,600,000 | 199,100,000 | 199,100,000 | 198,700,000 | · | 49,500,000 | 49,500,000 | 49,400,000 | · |
Cashflow
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $95M | $95M | $96M | $98M | $95M | $93M | $91M | $91M | $89M | $98M | $97M | $93M | $94M | $91M | $90M | $89M | |
| Deferred Tax | $-275M | $44M | $44M | $13M | $44M | $44M | $35M | $22M | $36M | $32M | $29M | · | · | · | · | $-1M | |
| Amort. of Intangibles | $47M | $48M | $48M | $50M | $50M | $50M | $50M | $50M | $50M | $50M | $50M | $46M | $47M | $46M | $46M | $46M | |
| Other Non-cash | · | · | $-45M | · | · | · | $-115M | · | · | · | $-165M | · | · | · | $-36M | · | |
| Operating Cash Flow | $342M | $183M | $261M | $248M | $261M | $96M | $191M | $268M | $208M | $111M | $123M | $174M | $142M | $124M | $167M | $131M | |
| CapEx | $69M | $86M | $102M | $98M | $97M | $78M | $89M | $140M | $89M | $74M | $118M | $145M | $91M | $74M | $83M | $95M | |
| Investing Cash Flow | $-70M | $-90M | $-103M | $-99M | $-98M | $-79M | $-97M | $-242M | $-124M | $-75M | $-324M | $-161M | $-93M | $-82M | $-113M | $-100M | |
| Debt Issued | $1.11B | $858M | $875M | $936M | $756M | $749M | $670M | $716M | $1.40B | $608M | $795M | $472M | $453M | $497M | $702M | $12M | |
| Net Debt Issued | · | · | $-29M | · | · | · | $-59M | · | · | · | $202M | · | · | · | $276M | · | |
| Stock Repurchased | $339M | $16M | $92M | $197M | $53M | $41M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | · | $-92M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Dividends Paid | · | · | · | · | · | · | · | $0 | $0 | · | · | $2M | $0 | · | · | $2M | |
| Financing Cash Flow | $-253M | $-76M | $-148M | $-164M | $-156M | $-9M | $-97M | $-28M | $-88M | $-57M | $212M | $-6M | $-43M | $-47M | $-78M | $-134M | |
| Net Change in Cash | $16M | $14M | $14M | $-14M | $9M | $15M | $-7M | $-2M | $-3M | $-23M | $14M | $3M | $5M | $-6M | $-20M | $-108M | |
| Free Cash Flow | · | · | $159M | · | · | · | $101M | · | · | · | $5M | · | · | · | $84M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-16M | · | · | · | $66M | · |
Rentabilität
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.8% | 68.0% | 67.9% | · | 65.3% | 67.8% | 68.4% | · | 66.1% | 67.0% | 67.0% | · | 65.6% | 66.4% | 65.1% | · | |
| Operating Margin | 20.8% | -2.9% | 20.8% | · | 16.6% | 18.4% | 18.9% | · | 19.2% | 17.2% | 16.4% | · | 16.3% | 11.0% | 17.4% | · | |
| Net Margin | 40.6% | -7.2% | 12.8% | · | 9.3% | 8.8% | 10.8% | · | 10.4% | 9.4% | 8.7% | · | 9.2% | 4.5% | 9.8% | · | |
| Pretax Margin | 18.9% | -4.5% | 18.8% | · | 14.3% | 14.4% | 15.9% | · | 16.3% | 13.8% | 12.9% | · | 12.8% | 7.5% | 14.2% | · | |
| EBITDA Margin | 20.8% | -2.9% | 30.1% | · | 16.6% | 18.4% | 28.3% | · | 19.2% | 17.2% | 26.8% | · | 16.3% | 11.0% | 27.9% | · | |
| ROA | 3.5% | -0.63% | 1.1% | · | 0.80% | 0.72% | 0.86% | · | 0.88% | 0.75% | 0.69% | · | 0.73% | 0.34% | 0.73% | · | |
| ROE | 5.2% | -0.94% | 1.6% | · | 1.2% | 1.1% | 1.3% | · | 1.4% | 1.2% | 1.1% | · | 1.2% | 0.55% | 1.2% | · | |
| ROIC | 4.4% | -0.47% | 1.3% | · | 1.1% | 1.0% | 1.2% | · | 1.2% | 1.1% | 0.99% | · | 1.1% | 0.58% | 1.0% | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.3 | 1.3 | · | 2.1 | 2.1 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 1.7 | 1.7 | 1.7 | · | |
| Quick Ratio | 0.5 | 0.5 | 0.6 | · | 0.9 | 0.9 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.8 | · | |
| Debt / Equity | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | |
| LT Debt / Equity | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.6 | 5.1 | · | 5.7 | 3.7 | 5.7 | · |
Effizienz
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | |
| Inventory Turnover | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | |
| Receivables Turnover | 1.3 | 1.4 | 1.3 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · |
Pro Aktie
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $43.81 | $42.27 | $42.87 | · | $42.02 | $41.54 | $40.66 | · | $39.80 | $39.19 | $38.73 | · | $152.09 | $149.05 | $148.49 | · | |
| Revenue / Share | $5.51 | $5.55 | $5.21 | · | $5.30 | $4.99 | $4.79 | · | $5.00 | $4.70 | $4.66 | · | $18.64 | $17.62 | $17.27 | · | |
| Cash Flow / Share | · | · | $1.33 | · | · | · | $0.95 | · | · | · | $0.61 | · | · | · | $3.35 | · | |
| Cash / Share | $0.81 | $0.71 | $0.64 | · | $0.63 | $0.58 | $0.50 | · | $0.55 | $0.56 | $0.68 | · | $2.37 | $2.26 | $2.39 | · | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | · | · | $0.01 | · | $0.01 | · | |
| EPS (TTM) | $2.92 | $1.17 | $2.01 | · | $2.04 | $2.07 | $2.07 | · | $1.79 | $1.70 | $1.46 | · | $-3.44 | $-1.89 | $0.46 | · |
Bewertung (TTM)
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.24B | $4.23B | $4.15B | · | $4.05B | $3.99B | $3.93B | · | $3.80B | $3.73B | $3.67B | · | $3.51B | $3.43B | $3.38B | · | |
| Net Income TTM | $570M | $236M | $401M | · | $408M | $414M | $415M | · | $359M | $340M | $291M | · | $275M | $288M | $375M | · | |
| Market Cap | $13.75B | $12.26B | $15.81B | · | $14.05B | $16.29B | $19.30B | · | $18.58B | $17.73B | $18.53B | · | $4.84B | $4.72B | $4.31B | · | |
| Enterprise Value | $16.14B | $14.58B | $18.18B | · | $16.40B | $18.76B | $21.74B | · | $21.10B | $20.33B | $21.16B | · | $7.30B | $7.23B | $6.87B | · | |
| P/E | 24.8 | 53.8 | 40.3 | · | 34.7 | 39.5 | 46.6 | · | 52.1 | 52.4 | 63.9 | · | -28.4 | -50.5 | 189.6 | · | |
| P/S | 3.2 | 2.9 | 3.8 | · | 3.5 | 4.1 | 4.9 | · | 4.9 | 4.8 | 5.1 | · | 1.4 | 1.4 | 1.3 | · | |
| P/B | 1.7 | 1.5 | 1.9 | · | 1.7 | 2.0 | 2.4 | · | 2.3 | 2.3 | 2.4 | · | 0.6 | 0.6 | 0.6 | · | |
| P / Tangible Book | 4.6 | 4.3 | 5.4 | · | 4.9 | 6.0 | 7.4 | · | 7.9 | 7.9 | 8.9 | · | 2.3 | 2.5 | 2.4 | · | |
| P / Cash Flow | · | · | 60.6 | · | · | · | 101.3 | · | · | · | 151.0 | · | · | · | 25.9 | · | |
| EV / Revenue | 3.8 | 3.4 | 4.4 | · | 4.1 | 4.7 | 5.5 | · | 5.5 | 5.4 | 5.8 | · | 2.1 | 2.1 | 2.0 | · | |
| Earnings Yield | 4.0% | 1.9% | 2.5% | · | 2.9% | 2.5% | 2.1% | · | 1.9% | 1.9% | 1.6% | · | -3.5% | -2.0% | 0.53% | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Umsatz | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B |
| Bruttogewinnmarge % | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% |
| Betriebsgewinnmarge % | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% |
| Nettoergebnis | $375M | $392M | $294M | $386M | $2.94B |
| Verwässerte EPS | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 |
| Kennzahl | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 |
| Liquiditätsgrad | 1.9 | 1.9 | 1.8 | 1.2 | 2.0 |
| Quick Ratio | 0.8 | 0.8 | 0.8 | 0.5 | 0.8 |
| Kennzahl | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $434M | $288M | $215M | $450M | $524M |
Institutionelle Eigentümer (13F) 734 Einreicher · $15.9B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
734
Gehaltener Wert
$15.9B
Neue Positionen
110
Geschlossene Positionen
98
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 110 (-5 vs. Vorquartal) | 98 (+14 vs. Vorquartal) | 259 (+25 vs. Vorquartal) | 236 (-6 vs. Vorquartal) | +2.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.930.069.728 | 23.548.923 | 12,11% | Aktien |
| BlackRock, Inc. | $1.077.762.042 | 15.029.453 | 6,76% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $914.931.325 | 12.758.769 | 5,74% | Aktien |
| STATE STREET CORP | $637.691.430 | 8.892.643 | 4,00% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $621.703.470 | 8.669.690 | 3,90% | Aktien |
| BROWNING WEST LP | $515.984.142 | 7.195.428 | 3,24% | Aktien |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $389.405.563 | 5.430.282 | 2,44% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $382.865.202 | 5.359.812 | 2,40% | Aktien |
| FRANKLIN RESOURCES INC | $365.497.867 | 5.096.888 | 2,29% | Aktien |
| GENERATION INVESTMENT MANAGEMENT LLP | $356.303.541 | 4.968.673 | 2,24% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $287.152.440 | 4.004.357 | 1,80% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $285.686.067 | 4.022.614 | 1,79% | Aktien |
| Longview Partners (Guernsey) LTD | $282.537.902 | 3.940.007 | 1,77% | Aktien |
| UBS Group AG | $281.964.653 | 3.932.013 | 1,77% | Aktien |
| CITADEL ADVISORS LLC | $277.689.589 | 3.872.397 | 1,74% | Aktien |
| Invesco Ltd. | $264.254.073 | 3.685.038 | 1,66% | Aktien |
| JANA Partners Management, LP | $256.899.641 | 3.582.480 | 1,61% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $248.758.476 | 3.468.951 | 1,56% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $239.621.575 | 3.341.607 | 1,50% | Aktien |
| JANUS HENDERSON GROUP PLC | $219.298.853 | 3.067.125 | 1,38% | Aktien |
| LONDON CO OF VIRGINIA | $207.821.082 | 2.898.075 | 1,30% | Aktien |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $195.854.209 | 2.731.198 | 1,23% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $187.836.665 | 2.343.776 | 1,18% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $180.899.937 | 2.530.069 | 1,14% | Aktien |
| BARCLAYS PLC | $152.030.580 | 2.120.075 | 0,95% | Aktien |
| BANK OF AMERICA CORP /DE/ | $144.125.264 | 2.009.835 | 0,90% | Aktien |
| River Road Asset Management, LLC | $142.048.546 | 1.980.875 | 0,89% | Aktien |
| Sustainable Growth Advisers, LP | $139.698.824 | 1.948.108 | 0,88% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $132.231.017 | 1.843.969 | 0,83% | Aktien |
| MORGAN STANLEY | $129.451.390 | 1.805.205 | 0,81% | Aktien |
| NORTHERN TRUST CORP | $122.198.356 | 1.704.063 | 0,77% | Aktien |
| Gates Capital Management, Inc. | $121.088.717 | 1.688.589 | 0,76% | Aktien |
| Alecta Tjanstepension Omsesidigt | $112.082.730 | 1.563.000 | 0,70% | Aktien |
| MANNING & NAPIER ADVISORS LLC | $107.938.609 | 1.505.210 | 0,68% | Aktien |
| GOLDMAN SACHS GROUP INC | $107.170.245 | 1.494.495 | 0,67% | Aktien |
| Amundi | $101.548.173 | 1.416.095 | 0,64% | Aktien |
| Focus Partners Wealth | $101.143.265 | 1.410.461 | 0,63% | Aktien |
| Findlay Park Partners LLP | $92.075.640 | 1.284.000 | 0,58% | Aktien |
| WELLS FARGO & COMPANY/MN | $82.870.197 | 1.155.630 | 0,52% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $78.580.965 | 1.095.816 | 0,49% | Aktien |
| Holocene Advisors, LP | $77.495.348 | 1.080.677 | 0,49% | Aktien |
| Bank of New York Mellon Corp | $73.642.162 | 1.026.945 | 0,46% | Aktien |
| Balyasny Asset Management L.P. | $71.022.946 | 990.419 | 0,45% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $69.128.942 | 964.007 | 0,43% | Aktien |
| FMR LLC | $66.919.501 | 933.197 | 0,42% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $63.808.602 | 889.815 | 0,40% | Aktien |
| JPMORGAN CHASE & CO | $63.430.969 | 879.426 | 0,40% | Aktien |
| DEUTSCHE BANK AG\ | $61.203.267 | 853.483 | 0,38% | Aktien |
| Legal & General Group Plc | $60.521.302 | 843.973 | 0,38% | Aktien |
| TORONTO DOMINION BANK | $56.349.846 | 785.802 | 0,35% | Aktien |
Unternehmensinsider 51 Insider · 25 Führungskräfte · 21 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert D Auerbach | Special Advisor to the CEO | 1. Februar 2021 M | 2.759 | 0 | 0 | $0 |
| REMMELL PAUL L | Pres & CEO - CooperSurgical | 14. Juli 2017 M | 1.352 | 0 | 0 | $0 |
| Nicholas J Pichotta | Pres, CEO Cooper Medical, Inc. | 8. Januar 2014 M | 10.697 | 0 | 0 | $0 |
| Brian G Andrews | EVP, CFO & Treasurer | 10. Dezember 2024 A | 8.537 | 0 | 0 | $0 |
| Gregory W Matz | SVP, CFO & CRO | 13. Juni 2016 M | 15.123 | 0 | 0 | $0 |
| Steven M Neil | EVP & CFO | 16. Januar 2008 P | 4.300 | 0 | 0 | $0 |
| John J Calcagno | CFO - CooperVision | 25. Oktober 2007 A | 0 | 0 | 0 | $0 |
| Gerard H Warner III | President, CooperVision, Inc. | 8. Januar 2026 M | 23.852 | 0 | 0 | $0 |
| Holly R Sheffield | President, CSI | 8. Januar 2026 M | 43.261 | 1 | 0 | $99.322 |
| John Arthur Weber | President, CooperVision, Inc. | 8. Januar 2014 M | 15.260 | 0 | 0 | $0 |
| Dennis Murphy | President Americas, CVI | 11. September 2009 M | 0 | 0 | 0 | $0 |
| Gregory A Fryling | Pres & COO - CVI | 24. Oktober 2006 A | 3.790 | 0 | 0 | $0 |
| Agostino Ricupati | SVP & CAO | 1. April 2025 M | 8.020 | 0 | 0 | $0 |
| Nicholas Khadder | VP, General Counsel & Corp Sec | 8. Januar 2025 M | 2.506 | 0 | 0 | $0 |
| Mark J Drury | VP, General Counsel & Sec. | 8. Januar 2022 M | 2.197 | 0 | 0 | $0 |
| Randal Golden | VP, General Counsel & Sec. | 3. Februar 2020 M | 1.673 | 0 | 0 | $0 |
| Carol R Kaufman | EVP, Sec. & Chief Gov. Officer | 11. April 2018 G | 45.898 | 0 | 0 | $0 |
| Tina Maloney | VP, Corporate Controller | 8. Januar 2017 M | 2.874 | 0 | 0 | $0 |
| Rodney Folden | VP & Corporate Controller | 8. Januar 2014 M | 8.592 | 0 | 0 | $0 |
| Eugene J Midlock | VP Tax | 9. Januar 2012 M | 2.137 | 0 | 0 | $0 |
| Jeffrey Alan Mclean | Exec VP, Comm. Strategies-CVI | 11. Dezember 2008 A | 0 | 0 | 0 | $0 |
| Christopher J Marmo | VP, R&D of CooperVision, Inc. | 24. Oktober 2006 A | · | 0 | 0 | $0 |
| Norris B Battin | VP, Investor Relations | 24. Oktober 2006 A | 4.000 | 0 | 0 | $0 |
| David Acosta | Treasurer | 8. April 2005 S | 10.000 | 0 | 0 | $0 |
| Stephen Whiteford | VP, Corporate Controller | 20. Januar 2004 M | 15.052 | 0 | 0 | $0 |
| Lawrence E. Kurzius | Direktor | 16. September 2026 P | 31.099 | 3 | 0 | $1.253.500 |
| Walter M Rosebrough Jr | Direktor | 14. September 2026 P | 20.000 | 2 | 0 | $541.640 |
| Keel Paul A | Direktor | 11. September 2026 P | 4.701 | 1 | 0 | $249.999 |
| Barbara Carbone | Direktor | 1. April 2026 A | 3.050 | 0 | 0 | $0 |
| Maria Rivas | Direktor | 1. April 2026 A | 3.322 | 1 | 0 | $82.130 |
| Colleen Jay | Direktor | 1. April 2026 A | 39.907 | 0 | 0 | $0 |
| Robert S Weiss | Direktor | 1. April 2026 A | 292.599 | 0 | 0 | $0 |
| MADDEN TERESA S | Direktor | 1. April 2026 A | 15.679 | 0 | 0 | $0 |
| William A Kozy | Direktor | 1. April 2025 M | 31.149 | 0 | 0 | $0 |
| Gary S Petersmeyer | Direktor | 22. März 2024 G | 1.523 | 0 | 0 | $0 |
| Jody S Lindell | Direktor | 6. Januar 2023 M | 13.543 | 0 | 0 | $0 |
| Michael Kalkstein | Direktor | 1. April 2020 M | 0 | 0 | 0 | $0 |
| Allan E Rubenstein | Direktor | 1. April 2020 A | 3.091 | 0 | 0 | $0 |
| Thomas A Bender | Direktor | 1. April 2020 A | 12.952 | 0 | 0 | $0 |
| Stanley Zinberg MD | Direktor | 12. März 2019 M | 10.528 | 0 | 0 | $0 |
| Steven Rosenberg | Direktor | 5. Januar 2016 A | 12.359 | 0 | 0 | $0 |
| Donald Press | Direktor | 7. Januar 2014 A | 43.970 | 0 | 0 | $0 |
| Moses Marx | Direktor | 1. Dezember 2009 A | 107.532 | 0 | 0 | $0 |
| FRUTH JOHN D | Direktor | 14. Januar 2008 A | 6.500 | 0 | 0 | $0 |
| Edgar J Cummins | Direktor | 27. Dezember 2005 S | 1.764 | 0 | 0 | $0 |
| COOPER COMPANIES INC | Direktor | 1. November 2004 A | · | 0 | 0 | $0 |
| Cynthia L Lucchese | · | 1. April 2026 A | 12.767 | 1 | 0 | $149.963 |
| Daniel G Mcbride | · | 8. Januar 2026 M | 69.352 | 0 | 0 | $0 |
| Albert G White III | · | 10. Dezember 2024 A | 245.072 | 1 | 0 | $808.000 |
| Andrew Sedgwick | · | 30. September 2009 M | 0 | 0 | 0 | $0 |
| James M Welch | · | 27. Oktober 2005 A | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 100 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2,96% | 18.688 NS | 31. Juli 2026 | N-PORT |
| EQTY · Valued Advisers Trust | 2,01% | 396.156 NS | 31. Juli 2026 | N-PORT |
| CVSM · Elevation Series Trust | 1,88% | 24.508 NS | 31. Juli 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 1,59% | 45.751 SH | 2. Oktober 2026 | Täglich |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,49% | 226.573 SH | 2. Oktober 2026 | Täglich |
| BSMQ · Invesco Exchange-Traded Self-Indexe… | 0,73% | 1.880.000 | 2. Oktober 2026 | Täglich |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0,56% | 115.249 SH | 2. Oktober 2026 | Täglich |
| FBCV · FIDELITY COVINGTON TRUST | 0,45% | 11.032 NS | 31. Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,43% | 61.771 NS | 31. Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,37% | 746.479 NS | 31. Juli 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,31% | 85.593 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,30% | 2.841.101 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,21% | 586.725 SH | 19. August 2026 | Täglich |
| BSMU · Invesco Exchange-Traded Self-Indexe… | 0,21% | 545.000 | 2. Oktober 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,20% | 92.713 NS | 31. Juli 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,18% | 3.074.683 SH | 2. Oktober 2026 | Täglich |
| SIZE · iShares Trust | 0,17% | 13.773 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,17% | 4.474.789 SH | 19. August 2026 | Täglich |
| IYH · iShares Trust | 0,17% | 114.003 SH | 11. September 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,16% | 3.839 NS | 31. Juli 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,14% | 50.851 SH | 11. September 2026 | Täglich |
| ISCG · iShares Trust | 0,14% | 25.105 SH | 11. September 2026 | Täglich |
| IXJ · iShares Trust | 0,13% | 102.346 SH | 11. September 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,13% | 142.024 NS | 31. Juli 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 7.195 NS | 31. Juli 2026 | N-PORT |
| EVUS · iShares Trust | 0,11% | 7.759 SH | 11. September 2026 | Täglich |
| IWS · iShares Trust | 0,10% | 290.845 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 13.955 SH | 2. Oktober 2026 | Täglich |
| BSMT · Invesco Exchange-Traded Self-Indexe… | 0,10% | 270.000 | 1. Oktober 2026 | Täglich |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,09% | 19.651 NS | 31. Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,08% | 796.790 SH | 11. September 2026 | Täglich |
| BAB · Invesco Exchange-Traded Fund Trust … | 0,07% | 592.000 | 1. Oktober 2026 | Täglich |
| BSMR · Invesco Exchange-Traded Self-Indexe… | 0,06% | 215.000 | 2. Oktober 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,06% | 7.148 SH | 19. August 2026 | Täglich |
| XOEF · iShares Trust | 0,06% | 245 SH | 11. September 2026 | Täglich |
| VLUE · iShares Trust | 0,06% | 105.585 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,05% | 3.837 NS | 31. Juli 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,05% | 44.755 SH | 19. August 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,05% | 103.993 NS | 31. Juli 2026 | N-PORT |
| BSMS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 155.000 | 1. Oktober 2026 | Täglich |
| CHRI · Global X Funds | 0,04% | 47 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,04% | 266.539 NS | 31. Juli 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 117.246 SH | 19. August 2026 | Täglich |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 6.136 SH | 2. Oktober 2026 | Täglich |
| IVE · iShares Trust | 0,04% | 325.198 SH | 11. September 2026 | Täglich |
| IUSV · iShares Trust | 0,03% | 172.535 SH | 11. September 2026 | Täglich |
| EGLE · Global X Funds | 0,03% | 10 NS | 31. Juli 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,03% | 5 NS | 31. Juli 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,03% | 9.255 SH | 2. Oktober 2026 | Täglich |
| SUSL · iShares Trust | 0,03% | 6.864 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,03% | 63.415 NS | 31. Juli 2026 | N-PORT |
| DSI · iShares Trust | 0,03% | 29.689 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,03% | 13.489 NS | 31. Juli 2026 | N-PORT |
| IWD · iShares Trust | 0,03% | 434.725 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,03% | 8.374 NS | 31. Juli 2026 | N-PORT |
| XRMI · Global X Funds | 0,03% | 190 NS | 31. Juli 2026 | N-PORT |
| CRBN · iShares Trust | 0,03% | 5.717 SH | 11. September 2026 | Täglich |
| XCLR · Global X Funds | 0,03% | 13 NS | 31. Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,03% | 225 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,03% | 43.268 NS | 31. Juli 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,02% | 42.256 SH | 2. Oktober 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,02% | 7.349 NS | 31. Juli 2026 | N-PORT |
| XYLD · Global X Funds | 0,02% | 9.976 NS | 31. Juli 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,02% | 16.763 NS | 31. Juli 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,02% | 9.935 NS | 31. Juli 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,02% | 456 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,02% | 61.254 NS | 31. Juli 2026 | N-PORT |
| XTR · Global X Funds | 0,02% | 14 NS | 31. Juli 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,02% | 736 NS | 31. Juli 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,02% | 5.069.056 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 6.191.667 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 31.957 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 16.452 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,02% | 43.944 SH | 19. August 2026 | Täglich |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,02% | 33.906 SH | 2. Oktober 2026 | Täglich |
| QDPL · Pacer Funds Trust | 0,02% | 4.676 NS | 31. Juli 2026 | N-PORT |
| TOPC · iShares Trust | 0,02% | 115 SH | 11. September 2026 | Täglich |
| XVV · iShares Trust | 0,02% | 2.209 SH | 11. September 2026 | Täglich |
| HCMT · Direxion Shares ETF Trust | 0,02% | 1.360 NS | 31. Juli 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,02% | 1.151 SH | 2. Oktober 2026 | Täglich |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,02% | 33.763 SH | 2. Oktober 2026 | Täglich |
| SPXL · Direxion Shares ETF Trust | 0,02% | 15.254 NS | 31. Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,02% | 2.459.565 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,02% | 8.448 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,02% | 55.887 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,02% | 134.163 SH | 11. September 2026 | Täglich |
| VOXP · Advisors Series Trust | 0,02% | 12 NS | 31. Juli 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 155 SH | 2. Oktober 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 251.738 SH | 11. September 2026 | Täglich |
| TOK · iShares Trust | 0,01% | 564 SH | 11. September 2026 | Täglich |
| URTH · iShares, Inc. | 0,01% | 18.452 SH | 11. September 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 9.210 SH | 2. Oktober 2026 | Täglich |
| ACWI · iShares Trust | 0,01% | 65.230 SH | 11. September 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 173.475 SH | 19. August 2026 | Täglich |
| FTLS · First Trust Exchange-Traded Fund III | -0,15% | -50.276 NS | 31. Juli 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 14. Juli 2026 | Täglich |
| ISCB · iShares Trust | · | 8.790 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 25.681 SH | 11. September 2026 | Täglich |
COO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 23 Analysten
KAUF
Median-Ziel
$65.50
+15,1%
6 26,1%
Starker Kauf
7 30,4%
Kauf
10 43,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
14 Analysten · 2026-10-04Mittelwert-Ziel $66.21 +16,3%
← Unter allen Zielen
Aktueller Preis $56.91
Tief$58.00
Mittelwert$66.21
Hoch$75.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| MDLN | · | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 1,92
Einstieg
$68.92
R:R 1,92
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 1,85
Einstieg
$70.55
R:R 1,85
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Sep 9, 2026